Kairos Therapeutics Overview
- Founded
- 2013
- Status
- Acquired/Merged
- Employees
- 7
- Latest Deal Type
- M&A
Kairos Therapeutics General Information
Description
Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform that enables development of therapeutics for the treatment of multiple forms of cancer.
Contact Information
Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 2405 Wesbrook Mall
- Fourth Floor
- Vancouver, British Columbia V6T 1Z3
- Canada
Kairos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 22-Mar-2016 | Completed | Startup | |||
| 1. Early Stage VC | 12-Dec-2013 | Completed | Startup |
Kairos Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform t
Biotechnology
Vancouver, Canada
7
As of 2016
000000&0
000 0000
adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
000000000 00000 (0000000000)
Chester, United Kingdom
00
As of 0000
000.00
000000000000
000.00
00000000
is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000 000000000
San Carlos, CA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialKairos Therapeutics Competitors (22)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ADC Biotechnology | Venture Capital-Backed | Chester, United Kingdom | 00 | 000.00 | 000000000000 | 000.00 |
| 00000000 | Venture Capital-Backed | San Carlos, CA | 00 | 00000 | 00000000000 | 00000 |
| 0000000 | Formerly Accelerator/Incubator backed | San Francisco, CA | 0 | 000000&0 | ||
| 000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 000000 00000000000 | Private Equity-Backed | Abingdon, United Kingdom | 00 | 000.00 | 0000000 0000 | 000.00 |
Kairos Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| John Babcook | Co-Founder, Chief Scientific Officer & President |
Kairos Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialKairos Therapeutics Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CDRD Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |